Antidepressants for smoking cessation

Cited by (1,000)

Items 501–600 of 1,000

1. Depression, diabetes, and chronic disease risk factors among US women of reproductive age.
   Sherry L. Farr, Donald Hayes, Rebecca H. Bitsko, Pooja Bansil, Patricia M. Dietz · 2011 · Europe PMC (PubMed Central)
2. Effectiveness of smoking cessation interventions among adults: an overview of systematic reviews
   Mona Hersi, Andrew Beck, Candyce Hamel, Leila Esmaeilisaraji, Kusala Pussegoda, Bradley Austin, Nadera Ahmadzai, Misty Pratt, Micere Thuku, Fatemeh Yazdi et al. · 2024 · Systematic Reviews
3. Effects of exercise on craving and cigarette smoking in the human laboratory
   Allison Nicole Kurti, Jesse Dallery · 2014 · Addictive Behaviors
4. Effects of Tobacco Smoke Exposure in Childhood on Atopic Diseases
   Christina E. Ciaccio, Deborah Ann Gentile · 2013 · Current Allergy and Asthma Reports
5. Betel quid dependence mechanism and potential cessation therapy
   Albert Min‐Shan Ko, Chien‐Hung Lee, Allen Min-Jen Ko, Ying‐Chin Ko · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
6. New treatments for chronic obstructive pulmonary disease
   Peter John Barnes · 2001 · Current Opinion in Pharmacology
7. Management of anxiety and depression in patients with COPD
   Abebaw Mengistu Yohannes · 2008 · Expert Review of Respiratory Medicine
8. Recomendaciones para el tratamiento farmacológico del tabaquismo. Propuestas de financiación
   Carlos Andrés Jimenez-Ruiz, Juan Antonio Riesco Miranda, Ángela Ramos Pinedo, Miguel Barrueco Ferrero, Segismundo Solano Reina, José Ignacio de Granda Orive, Jesús Grávalos Guzmán, Lourdes Ramos Casado, Alfonso Pérez Trullén, Karl Olov Fagerström · 2008 · Archivos de Bronconeumología
9. Sex differences in attitudes and experiences concerning smoking and cessation: Results from an international survey
   Robert D. Reid, Andrew Pipe, Dana L. Riley, Michelle Sørensen · 2008 · Patient Education and Counseling
10. Individual Consistency of Feather Pecking Behavior in Laying Hens: Once a Feather Pecker Always a Feather Pecker?
    Courtney Lynd Daigle, T.B. Rodenburg, Jantina Elizabeth Bolhuis, Janice C. Swanson, Janice M. Siegford · 2015 · Frontiers in Veterinary Science
11. Physical activity as an aid to smoking cessation during pregnancy: Two feasibility studies
    MICHAEL H USSHER, Paul N Aveyard, Tim J Coleman, Lianne Straus, Robert West, Bess H. Marcus, Beth A. Lewis, Isaac Manyonda · 2008 · BMC Public Health
12. Treatment of Tobacco Dependence
    Michael V. Burke, Jon O. Ebbert, James Taylor Hays · 2008 · Mayo Clinic Proceedings
13. A Standardized Transcutaneous Electric Acupoint Stimulation for Relieving Tobacco Urges in Dependent Smokers
    Caroline Lambert, Ivan Berlin, Tat‐Leang Lee, Siew Wan Hee, Audrey SL Tan, D. Picard, Ji Sheng Han · 2008 · Evidence-based Complementary and Alternative Medicine
14. Pharmacological Smoking Cessation Therapies in Older Adults: A Review of the Evidence
    Philip B. Cawkwell, Caroline S. Blaum, Scott E. Sherman · 2015 · Drugs & Aging
15. Milestones in the journey towards addressing obesity; Past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical therapies and integration of effective medical therapies with metabolic surgery
    Michail Kokkorakis, Angeliki Katsarou, Niki Katsiki, Christos Socrates Mantzoros · 2023 · Metabolism
16. Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment
    Daniel F. Heitjan, David A. Asch, Riju Ray, Margaret R. Rukstalis, Freda Patterson, Caryn E. Lerman · 2008 · The Pharmacogenomics Journal
17. Varenicline in the management of smoking cessation: a single technology appraisal
    Daniel Hind, Paul Tappenden, Jean Peters, K Kenjegalieva · 2009 · Health Technology Assessment
18. Guidelines for Smoking Cessation
    Paparangi Reid · 2004
19. Effects of tobacco smoke constituents, anabasine and anatabine, on memory and attention in female rats
    Edward D. Levin, Ian Hao, Dennis A. Burke, Marty C. Cauley, Brandon J. Hall, Amir H. Rezvani · 2014 · Journal of Psychopharmacology
20. An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation
    Kenneth A. Perkins, Caryn E. Lerman · 2013 · Psychopharmacology
21. A comparative study on tobacco cessation methods: a quantitative systematic review.
    Gholamreza Heydari, Mohammadreza Masjedi, Arezoo Ebn Ahmady, Scott James Leischow, Harry Alan Lando, Mohammad Behgam Shadmehr, Lida Fadaizadeh · 2014 · PubMed Central
22. Understanding implementation and feasibility of tobacco cessation in routine primary care in Nepal: a mixed methods study
    Helen Elsey, Sudeepa Khanal, Shraddha Manandhar, Dilip Sah, Sushil Baral, Kamran Siddiqi, James Nicholas Newell · 2015 · Implementation Science
23. PUBLIC INSURANCE EXPANSIONS AND SMOKING CESSATION MEDICATIONS
    Johanna Catherine Maclean, Michael F. Pesko, Steven C. Hill · 2019 · Economic Inquiry
24. Guía de práctica clínica de la Sociedad Interamericana de Cardiología sobre prevención primaria de enfermedad cardiovascular en la mujer
    Mildren Del Sueldo, Maria Alayde Mendonça Rivera, Martha Beatriz Sanchez-Zambrano, Judith Miriam Zilberman, Ana G Múnera, María Paniagua, Lourdes Campos-Alcántara, Claudia Almonte, Amalia Paix-Gonzales, Claudia V. Anchique-Santos et al. · 2022 · Archivos de cardiología de México
25. NHG-Standaard COPD
    I J M Smeele, C.P. van Schayck, Onno C. P. van Schayck, Thys van der Molen, Bart P. A. Thoonen, Tjard R. Schermer, A P E Sachs, Jean W. M. Muris, Niels Henrik Chavannes, B G Kolnaar et al. · 2009 · Bohn Stafleu van Loghum eBooks
26. Physical activity as an aid to smoking cessation during pregnancy (LEAP) trial: study protocol for a randomized controlled trial
    MICHAEL H USSHER, Paul N Aveyard, Isaac Manyonda, Sarah Lewis, Robert West, Beth A. Lewis, Bess H. Marcus, Adrian Haffner Taylor, Pelham M Barton, Tim J Coleman · 2012 · Trials
27. Encouraging Smokers to Quit
    J Kaper, Edwin J. Wagena, Onno C. P. van Schayck, Johan Louis Severens · 2006 · PharmacoEconomics
28. Bupropion for Smoking Cessation: A Review
    Elisa K. Tong, Timothy P. Carmody, Joel A. Simon · 2006 · Comprehensive Therapy
29. Smoking Cessation in Chronic Obstructive Pulmonary Disease
    Stefan Andreas, Thomas Hering, Stephan Mühlig, Dennis Nowak, Tobias Raupach, H. Worth · 2009 · Deutsches Ärzteblatt international
30. Targeting nicotine addiction: the possibility of a therapeutic vaccine
    José Juan Escobar‐Chávez · 2011 · Drug Design Development and Therapy
31. A placebo-controlled trial of modafinil for nicotine dependence
    Robert A. Schnoll, E. Paul Wileyto, Angela G. Pinto, Frank T. Leone, Peter Gariti, Steven J. Siegel, Kenneth A. Perkins, Charles A. Dackis, Daniel F. Heitjan, Wade H. Berrettini et al. · 2008 · Drug and Alcohol Dependence
32. Systematic review and meta-analysis of opioid antagonists for smoking cessation
    Sean P. David, Isabella M. Chu, Tim Lancaster, Lindsay F Stead, Anne Eden Evins, Judith J. Prochaska · 2014 · BMJ Open
33. Prospective Association of Dopamine-Related Polymorphisms with Smoking Cessation in General Care
    Lutz Philipp Breitling, Dorothee Twardella, Michael M. Hoffmann, Stephanie H. Witt, Jens Treutlein, Hermann Brenner · 2010 · Pharmacogenomics
34. Animal Models and the Development of Vaccines to Treat Substance Use Disorders
    Odochi Ohia-Nwoko, Therese A. Kosten, Colin N. Haile · 2016 · International review of neurobiology
35. Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses
    Nicola Lindson, Annika Theodoulou, Jonathan Livingstone‐Banks, Paul N Aveyard, Thomas R. Fanshawe, José Manuel Ordóñez-Mena, Alex J. Sutton, Suzanne C Freeman, Sanjay Agrawal, Jamie Hartmann‐Boyce · 2022 · Cochrane Database of Systematic Reviews
36. Exercise-based Smoking Cessation Interventions among Women
    Sarah Linke, Joseph T. Ciccolo, MICHAEL H USSHER, Bess H. Marcus · 2012 · Women s Health
37. Stealing a March in the 21st Century: Accelerating Progress in the 100-Year War Against Tobacco Addiction in the United States
    Michael C. Fiore, Timothy B. Baker · 2009 · American Journal of Public Health
38. Effectiveness of intensive practice nurse counselling versus brief general practitioner advice, both combined with varenicline, for smoking cessation: a randomized pragmatic trial in primary care
    Carolien van Rossem, Mark Spigt, Wolfgang Viechtbauer, Annelies E. M. Lucas, Onno C. P. van Schayck, Daniel Kotz · 2017 · Addiction
39. IPCRG Consensus statement: Tackling the smoking epidemic — practical guidance for primary care
    Onno C. P. van Schayck, Hilary Pinnock, Anders Østrem, John Litt, Ron Tomlins, Siân Williams, Johan Buffels, Dimitri Giannopoulos, Svein Høegh Henrichsen, J Kaper et al. · 2008 · Primary Care Respiratory Journal
40. Pharmacological Tobacco Cessation Treatments: Proposals for Financing
    Carlos Andrés Jimenez-Ruiz, Juan Antonio Riesco Miranda, Ángela Ramos Pinedo, Miguel Barrueco Ferrero, Segismundo Solano Reina, José Ignacio de Granda Orive, Jesús Grávalos Guzmán, Lourdes Ramos Casado, Alfonso Pérez Trullén, Karl Olov Fagerström · 2008 · Archivos de Bronconeumología
41. Grey Lungs and Blue Moods: Smoking Cessation in the Context of Lifetime Depression History
    Kay A Wilhelm, Kay A Wilhelm, Karen Arnold, Heather Niven, ROBYN L. RICHMOND · 2004 · Australian & New Zealand Journal of Psychiatry
42. Bupropion SR for smoking cessation
    Robert West · 2003 · Expert Opinion on Pharmacotherapy
43. Pharmacological interventions on smoking cessation: A systematic review and network meta-analysis
    Xue Shang, Kangle Guo, E Fenfen, Xinxin Deng, Yongsheng Wang, Ziyi Wang, Yanan Wu, Meng Xu, Chaoqun Yang, Xiuxia Li et al. · 2022 · Frontiers in Pharmacology
44. Update on medicines for smoking cessation
    Mike McDonough · 2015 · Australian Prescriber
45. Activation of PPARγ Attenuates the Expression of Physical and Affective Nicotine Withdrawal Symptoms through Mechanisms Involving Amygdala and Hippocampus Neurotransmission
    Esi Domi, Francesca Felicia Caputi, Patrizia Romualdi, Ana Domi, Giulia Scuppa, Sanzio Candeletti, Alison L. Atkins, Markus A Heilig, Gregory A. Demopulos, George Gaitanaris et al. · 2019 · Journal of Neuroscience
46. Food Addiction and Tobacco Use Disorder: Common Liability and Shared Mechanisms
    Laurie A. Zawertailo, Sophia Attwells, Wayne K. deRuiter, Thao Lan Le, Danielle Dawson, Peter L. Selby · 2020 · Nutrients
47. NHG-Standaard Stoppen met roken
    H N Chavannes, J Kaper, D B Frijling, R J Van der Laan, M W P Jansen, S Guerrouj, M J A Drenthen, Willem A. Bax, A L Wind · 2009 · Bohn Stafleu van Loghum eBooks
48. What is effective intervention? – using theories of health promotion
    Karen Davies · 2006 · British Journal of Nursing
49. Systematic Review and Meta-Analysis of the Effects of Acupoint Stimulation on Smoking Cessation
    Hsiao-Min Cheng, Yu‐Chu Chung, Hsing‐Hsia Chen, Yung‐Hsien Chang, Mei‐Ling Yeh · 2012 · The American Journal of Chinese Medicine
50. Should All Smokers Use Combination Smoking Cessation Pharmacotherapy? Using Novel Analytic Methods to Detect Differential Treatment Effects Over 8 Weeks of Pharmacotherapy
    Wei‐Yin Loh, Megan E. Piper, Tanya R. Schlam, M. C. Fiore, Stevens S. Smith, Douglas E. Jorenby, J. W. Cook, Daniel M. Bolt, T. B. Baker · 2011 · Nicotine & Tobacco Research
51. Reporting of pain by people with chronic obstructive pulmonary disease (COPD): comparative results from the HUNT3 population-based survey
    Randi Andenæs, Astrid Momyr, Idunn Brekke · 2018 · BMC Public Health
52. Smoking Cessation Interventions in Cardiovascular Patients
    Louise C. W. Wiggers, Ellen M. A. Smets, Johanna C. J. M. de Haes, Ron J.G. Peters, Dink A. Legemate · 2003 · European Journal of Vascular and Endovascular Surgery
53. Chronic obstructive pulmonary disease * 8: Non-pharmacological management of COPD
    Michael D.L. Morgan · 2003 · Thorax
54. Smoking cessation-recent advances
    McNeil, John J., Piccenna, Loretta, Ioannides-Demos, Lisa L. · 2010 · Cardiovascular Drugs and Therapy
55. Varenicline Dose Dependently Enhances Responding for Nonpharmacological Reinforcers and Attenuates the Reinforcement-Enhancing Effects of Nicotine
    M. E. Levin, M. T. Weaver, Matthew Ian Palmatier, Anthony R. Caggiula, Alan F. Sved, Eric C. Donny · 2011 · Nicotine & Tobacco Research
56. Promoting smoking cessation in Pakistani and Bangladeshi men in the UK: pilot cluster randomised controlled trial of trained community outreach workers
    Rachna A Begh, Paul N Aveyard, Penney Upton, Raj S. Bhopal, Martin J. White, Amanda Amos, Robin John Prescott, Raman Bedi, Pelham M Barton, Monica J. Fletcher et al. · 2011 · Trials
57. The Prevalence of Cigarette Smoking Among Rural-to-Urban Migrants in China: A Systematic Review and Meta-Analysis
    Yao Liu, Jian Gao, Juan Shou, Huiling Xia, Yao Shen, Shanzhu Zhu, Zhigang Pan · 2016 · Substance Use & Misuse
58. Differential effects of perinatal exposure to antidepressants on learning and memory, acoustic startle, anxiety, and open‐field activity in Sprague‐Dawley rats
    Jenna L.N. Sprowles, Jillian R. H. Wendel, Arnold Gutierrez, Rebecca A. Bailey, Sarah A. Jablonski, Michael T. Williams, Charles V. Vorhees · 2017 · International Journal of Developmental Neuroscience
59. Impact of Substance Use Disorder Pharmacotherapy on Executive Function: A Narrative Review
    Kevin Butler, Bernard Le Foll · 2019 · Frontiers in Psychiatry
60. Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers
    Kari Linden, Vesa J. Jormanainen, Miika Linna, Harri Sintonen, Koo Wilson, Teija Kotomäki · 2010 · Current Medical Research and Opinion
61. Effectiveness of two intensive treatment methods for smoking cessation and relapse prevention in patients with coronary heart disease: study protocol and baseline description
    Nadine C. Berndt, Catherine A. W. Bolman, Lilian Lechner, Aart N. Mudde, Freek W.A. Verheugt, Hein de Vries · 2012 · BMC Cardiovascular Disorders
62. Effect of thought suppression on desire to smoke and tobacco withdrawal symptoms
    James Erskine, MICHAEL H USSHER, Mark Cropley, Abdelaziz Elgindi, Manzir Zaman, Bethan Corlett · 2011 · Psychopharmacology
63. Efficacy of Sequential Use of Fluoxetine for Smoking Cessation in Elevated Depressive Symptom Smokers
    Richard A. Brown, Ana M. Abrantes, David R. Strong, RAYMOND S. NIAURA, Christopher W. Kahler, Ivan W. Miller, Lawrence H. Price · 2013 · Nicotine & Tobacco Research
64. Sensory experiences and cues among E-cigarette users
    Jennifer DiPiazza, Pasquale Caponnetto, Gülce Askin, Paul J. Christos, Marilena Giovanna Maglia, R. Gautam, S. Roche, Riccardo Polosa · 2020 · Harm Reduction Journal
65. Clinical Practice Guideline of Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on Pharmacological Treatment of Tobacco Dependence 2023
    Carlos Rábade, José Ignacio de Granda‐Orive, Juan Antonio Riesco-Miranda, Eva de Higes-Martínez, Ángela Ramos Pinedo, Eva Cabrera-César, Jaime Signes-Costa Miñana, Marcos García-Rueda, Esther Pastor Esplá, Carlos Andrés Jimenez-Ruiz · 2023 · Archivos de Bronconeumología
66. The participation of health professionals in a smoking-cessation programme positively influences the smoking cessation advice given to patients
    Pekka Puska, M. Barrueco, Charalambos S. Roussos, A. Hider, S. Hogue · 2005 · International Journal of Clinical Practice
67. Involvement of rat dopaminergic system of nucleus accumbens in nicotine-induced anxiogenic-like behaviors
    Mohammad‐Reza Zarrindast, Solmaz Khalifeh, Ameneh Rezayof, Parvin Rostami, Arash Aghamohammadi‐Sereshki, Maryam Zahmatkesh · 2012 · Brain Research
68. The cytisine derivatives, CC4 and CC26, reduce nicotine-induced conditioned place preference in zebrafish by acting on heteromeric neuronal nicotinic acetylcholine receptors
    Luisa Ponzoni, Daniela Braida, Luca Pucci, Andrea Donzelli, Francesca Fasoli, Irene Manfredi, Roger L. Papke, Clare A. Stokes, Giuseppe Cannazza, Francesco Clementi et al. · 2014 · Psychopharmacology
69. Nicotine dependence – human and animal studies, current pharmacotherapies and future perspectives
    Magdalena Zaniewska, Edmund Przegaliński, Małgorzata Filip · 2009 · Pharmacological Reports
70. The Inclusion of Women and Minorities in Smoking Cessation Clinical Trials: A Systematic Review
    Daniel L. Dickerson, Robert Francis Leeman, Carolyn M. Mazure, Stephanie S. O’Malley · 2009 · American Journal on Addictions
71. What works in Indigenous tobacco control? The perceptions of remote Indigenous community members and health staff
    Vanessa Johnston, D. Thomas · 2010 · Health Promotion Journal of Australia
72. How confident should we be that smoking cessation treatments work?
    John R. Hughes · 2009 · Addiction
73. Tobacco Control Policies Specified According to Socioeconomic Status: Health Disparities and Cost-Effectiveness
    Eelco A. B. Over, Talitha Feenstra, Rudolf T. Hoogenveen, Mariël Droomers, Ellen Uiters, Boukje M. van Gelder · 2014 · Nicotine & Tobacco Research
74. Smoking cessation: present status and future perspectives
    Pasquale Caponnetto, Cristina Russo, Riccardo Polosa · 2012 · Current Opinion in Pharmacology
75. A second vaccine revolution for the new epidemics of the 21st century
    Mark R. Dyer, Wolfgang A. Renner, Martin F. Bachmann · 2006 · Drug Discovery Today
76. How pragmatic or explanatory is the randomized, controlled trial? The application and enhancement of the PRECIS tool to the evaluation of a smoking cessation trial
    Peter L. Selby, Gerald Brosky, PAUL I. OH, Vincent Raymond, Suzanne Ranger · 2012 · BMC Medical Research Methodology
77. An updated algorithm for choosing among smoking cessation treatments
    John R. Hughes · 2013 · Journal of Substance Abuse Treatment
78. An integrated approach to treat tobacco addiction in countries with high tuberculosis incidence
    Kamran Siddiqi, Andrew CK Lee · 2009 · Tropical Medicine & International Health
79. Update on pharmacologic and nonpharmacologic therapies for smoking cessation.
    Jason Schmelzle, Walter Rosser, Richard Birtwhistle · 2008 · Europe PMC (PubMed Central)
80. Smokers’ Interest in Quitting and Services Received: Using Practice Information to Plan Quality Improvement and Policy for Smoking Cessation
    Scott E. Sherman, Elizabeth Martin Yano, Andy B. Lanto, Barbara F. Simon, Lisa V. Rubenstein · 2005 · American Journal of Medical Quality
81. Pharmacological approaches to smoking cessation
    Ioanna Mitrouska, Izolde Bouloukaki, Nikolaos M. Siafakas · 2006 · Pulmonary Pharmacology & Therapeutics
82. Pharmacotherapy of Nicotine Dependence
    Knut-Olaf Haustein, David Alexander Groneberg · 2009 · Springer eBooks
83. The effectiveness of using e‐cigarettes for quitting smoking compared to other cessation methods among adults in the United Kingdom
    Máirtín S. McDermott, Katherine Amy East, Leonie S. Brose, Ann D. McNeill, Sara C Hitchman, Timea Partos · 2021 · Addiction
84. Converging vulnerability factors for compulsive food and drug use
    Katherine Marie Serafine, Laura E. O’Dell, Eric P. Zorrilla · 2021 · Neuropharmacology
85. Non‐invasive brain stimulation for smoking cessation: a systematic review and meta‐analysis
    Benjamin Petit, Alexandre Dornier, Vincent Meille, Anastasia Demina, Benoît Trojak · 2022 · Addiction
86. Cardiovascular Risk after Kidney Transplantation: Causes and Current Approaches to a Relevant Burden
    Francesco Reggiani, Gabriella Luisa Moroni, Claudio Ponticelli · 2022 · Journal of Personalized Medicine
87. Association between DRD2/ANKK1 Taq1A genotypes, depression and smoking cessation with nicotine replacement therapy
    John Stapleton, Gay Sutherland, Colin OʼGara, Lucy I. Spirling, David Ball · 2011 · Pharmacogenetics and Genomics
88. Bupropion and naltrexone for smoking cessation: A double‐blind randomized placebo‐controlled clinical trial
    ME Mooney, Joy M. Schmitz, SHARON S. ALLEN, John G. Grabowski, Paul R. Pentel, A Oliver, DK Hatsukami · 2016 · Clinical Pharmacology & Therapeutics
89. The economics of smoking and cardiovascular disease
    James M. Lightwood · 2003 · Progress in Cardiovascular Diseases
90. Interventions for smoking cessation in people diagnosed with lung cancer
    Linmiao Zeng, Xiaolian Yu, Tingting Yu, Xiao Jianhong, Yu‐Shan Huang · 2015 · Cochrane Database of Systematic Reviews
91. Estimates of effectiveness and reach for ‘return on investment’ modelling of smoking cessation interventions using data from England
    Robert West, Kathryn Coyle, Lesley Owen, Doug Coyle, Subhash Pokhrel, On behalf of the EQUIPT Study Group · 2017 · Addiction
92. Reprint of: Prevention and Treatment of Tobacco Use
    Sara M. Kalkhoran, Neal L. Benowitz, Nancy A. Rigotti · 2018 · Journal of the American College of Cardiology
93. Is the Antidepressant Activity of Selective Serotonin Reuptake Inhibitors Mediated by Nicotinic Acetylcholine Receptors?
    Hugo Rubén Arias, Katarzyna M. Targowska‐Duda, Jesús García‐Colunga, Marcelo O. Ortells · 2021 · Molecules
94. Consensus statement on smoking cessation in patients with pain
    Hiroki Iida, Shigeki Yamaguchi, Toru Goyagi, Yoko Sugiyama, Chie Taniguchi, Takako Matsubara, Naoto Yamada, Hiroshi Yonekura, Mami Iida · 2022 · Journal of Anesthesia
95. Crossing Borders: Factors Affecting Differences in Cost-Effectiveness of Smoking Cessation Interventions between European Countries
    Pepijn Vemer, Maureen Rutten‐van Mölken · 2009 · Value in Health
96. Bupropion effects on aggressiveness and anxiety in OF1 male mice
    Rosa Redolat, M. Carmen G�mez, Paloma Vicens, M. Carmen Carrasco · 2004 · Psychopharmacology
97. A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme
    Ali Ramazan Benli, Selman Erturhan, Muhammet Ali Oruç, Pinar Kalpakci, Didem Sunay, Yeltekin Demirel · 2017 · Tobacco Induced Diseases
98. Real-time video counselling for smoking cessation
    Flora Tzelepis, Christine Louise Paul, Christopher Michael Williams, Conor Gilligan, Tim W. Regan, Justine Daly, Rebecca Kate Hodder, John Henry Wiggers · 2017 · Cochrane Database of Systematic Reviews
99. Acute cholestatic hepatitis induced by bupropion prescribed as pharmacological support to stop smoking. A case report
    Domenico Alvaro, Andrea Onetti Muda, Rosanna Moscatelli, Adolfo Francesco Attili · 2001 · Digestive and Liver Disease
100. Tobacco Smoking: Current Concepts in Etiology and Treatment
     Ashwin A. Patkar, Michael J. Vergare, Vikas Batra, Steven P. Weinstein, Frank T. Leone · 2003 · Psychiatry